Tapewire

Nasdaq · USD

GOGO

Gogo Inc.

Export transactions ↓
Tapewire entity
5812
SEC CIK
0001537054
Parsed reports
764

Last 12 months

Inside the activity.

8 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202540
Dec 202520
Jan 202600
Feb 202600
Mar 202620
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 14, 2017 Filed Mar 16, 2017 21:11 UTC
Elias Marguerite MEVP, Gen Counsel and Secy
GrantPerformance Options (Right to Buy) · Derivative 29,840 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001209191-17-021135 · doc4.xml · derivative · entry 3

Elias Marguerite M · CIK 0001297509 · EVP, Gen Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,840

Underlying: Common Stock · 29,840 shares

Expires 2027-03-14

F3 · derivative.exercise_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited.

F3 · derivative.expiration_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:11 UTC
Elias Marguerite MEVP, Gen Counsel and Secy
GrantOptions (Right to Buy) · Derivative 58,340 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001209191-17-021135 · doc4.xml · derivative · entry 2

Elias Marguerite M · CIK 0001297509 · EVP, Gen Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,340

Underlying: Common Stock · 58,340 shares

Expires 2027-03-14

F2 · derivative.exercise_date: These options were granted on March 14, 2017 and are scheduled to vest and become exercisable in four equal annual installments on the first four anniversaries of the grant date, subject to continued employment with the Company.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:11 UTC
Elias Marguerite MEVP, Gen Counsel and Secy
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-021135 · doc4.xml · nonDerivative · entry 1

Elias Marguerite M · CIK 0001297509 · EVP, Gen Counsel and Secy

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,672

F1 · security: Includes restricted shares.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:10 UTC
COBIN JONATHAN BEVP, Chief Commercial Officer
GrantPerformance Restricted Stock Units · Derivative 3,840 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-021134 · doc4.xml · derivative · entry 4

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,840

Underlying: Common Stock · 3,840 shares

Expires not disclosed

F4 · derivative.exercise_price: Each performance restricted stock unit represents the contingent right to receive one share of the Company's common stock or its equivalent value in cash.

F5 · derivative.exercise_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited.

F5 · derivative.expiration_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:10 UTC
COBIN JONATHAN BEVP, Chief Commercial Officer
GrantPerformance Options (Right to Buy) · Derivative 29,840 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001209191-17-021134 · doc4.xml · derivative · entry 3

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,840

Underlying: Common Stock · 29,840 shares

Expires 2027-03-14

F3 · derivative.exercise_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited.

F3 · derivative.expiration_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:10 UTC
COBIN JONATHAN BEVP, Chief Commercial Officer
GrantOptions (Right to Buy) · Derivative 58,340 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001209191-17-021134 · doc4.xml · derivative · entry 2

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,340

Underlying: Common Stock · 58,340 shares

Expires 2027-03-14

F2 · derivative.exercise_date: These options were granted on March 14, 2017 and are scheduled to vest and become exercisable in four equal annual installments on the first four anniversaries of the grant date, subject to continued employment with the Company.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:10 UTC
COBIN JONATHAN BEVP, Chief Commercial Officer
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-021134 · doc4.xml · nonDerivative · entry 1

COBIN JONATHAN B · CIK 0001579480 · EVP, Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,653

F1 · security: Includes restricted shares.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:09 UTC
CHARI ANAND KEVP, Engineering and CTO
GrantPerformance Restricted Stock Units · Derivative 3,840 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-021132 · doc4.xml · derivative · entry 4

CHARI ANAND K · CIK 0001579594 · EVP, Engineering and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,840

Underlying: Common Stock · 3,840 shares

Expires not disclosed

F4 · derivative.exercise_price: Each performance restricted stock unit represents the contingent right to receive one share of the Company's common stock or its equivalent value in cash.

F5 · derivative.exercise_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited.

F5 · derivative.expiration_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:09 UTC
CHARI ANAND KEVP, Engineering and CTO
GrantPerformance Options (Right to Buy) · Derivative 29,840 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001209191-17-021132 · doc4.xml · derivative · entry 3

CHARI ANAND K · CIK 0001579594 · EVP, Engineering and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,840

Underlying: Common Stock · 29,840 shares

Expires 2027-03-14

F3 · derivative.exercise_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited.

F3 · derivative.expiration_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:09 UTC
CHARI ANAND KEVP, Engineering and CTO
GrantOptions (Right to Buy) · Derivative 58,340 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001209191-17-021132 · doc4.xml · derivative · entry 2

CHARI ANAND K · CIK 0001579594 · EVP, Engineering and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 58,340

Underlying: Common Stock · 58,340 shares

Expires 2027-03-14

F2 · derivative.exercise_date: These options were granted on March 14, 2017 and are scheduled to vest and become exercisable in four equal annual installments on the first four anniversaries of the grant date, subject to continued employment with the Company.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:09 UTC
CHARI ANAND KEVP, Engineering and CTO
GrantCommon Stock 10,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-021132 · doc4.xml · nonDerivative · entry 1

CHARI ANAND K · CIK 0001579594 · EVP, Engineering and CTO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,087

F1 · security: Includes restricted shares.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:08 UTC
Bayer Michael P.SVP, Controller & CAO
GrantPerformance Restricted Stock Units · Derivative 930 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-021127 · doc4.xml · derivative · entry 4

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 930

Underlying: Common Stock · 930 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance restricted stock unit represents the contingent right to receive one share of the Company's common stock or its equivalent value in cash.

F5 · derivative.exercise_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited.

F5 · derivative.expiration_date: The performance restricted stock units vest and are settled when they have both time vested and performance vested as follows: (i) the performance restricted stock units time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance restricted stock units performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance restricted stock unit that has not performance vested by March 14, 2021 shall be forfeited.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:08 UTC
Bayer Michael P.SVP, Controller & CAO
GrantPerformance Options (Right to Buy) · Derivative 7,710 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001209191-17-021127 · doc4.xml · derivative · entry 3

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,710

Underlying: Common Stock · 7,710 shares

Expires 2027-03-14

F4 · derivative.exercise_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited.

F4 · derivative.expiration_date: The performance options vest and become exercisable when they have both time vested and performance vested as follows: (i) the performance options time vest in equal annual installments on the first four anniversaries of March 14, 2017 and (ii) the performance options performance vest at such time, if any, as the per share closing price of Gogo common stock on the NASDAQ market during the period beginning on the grant date and ending on the fourth anniversary of March 14, 2017 equals or exceeds $25 for a period of 30 consecutive trading days. Any performance option that has not performance vested by March 14, 2021 shall be forfeited.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:08 UTC
Bayer Michael P.SVP, Controller & CAO
GrantOptions (Right to Buy) · Derivative 23,000 $0.00 Strike: $11.96 $0.00
Disclosure

SEC source: 0001209191-17-021127 · doc4.xml · derivative · entry 2

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2027-03-14

F3 · derivative.exercise_date: These options were granted on March 14, 2017 and are scheduled to vest and become exercisable in four equal annual installments on the first four anniversaries of the grant date, subject to continued employment with the Company.

Read SEC document
March 14, 2017 Filed Mar 16, 2017 21:08 UTC
Bayer Michael P.SVP, Controller & CAO
GrantRestricted Stock Units · Derivative 2,910 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-021127 · doc4.xml · derivative · entry 1

Bayer Michael P. · CIK 0001644203 · SVP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,110

Underlying: Common Stock · 2,910 shares

Expires not disclosed

F1 · derivative.exercise_price: Each performance restricted stock unit represents the contingent right to receive one share of the Company's common stock or its equivalent value in cash.

F2 · derivative.exercise_date: These restricted stock units vest in four equal installments on the first four anniversaries of March 14, 2017, subject to continued employment with the Company.

F2 · derivative.expiration_date: These restricted stock units vest in four equal installments on the first four anniversaries of March 14, 2017, subject to continued employment with the Company.

Read SEC document
March 02, 2017 Filed Mar 3, 2017 22:37 UTC Purchase3.75% Senior Convertible Notes due 2020 · Derivative Not disclosed $283,336.00 Strike: $23.85 $355,000.00
Disclosure

SEC source: 0001209191-17-017828 · doc4.xml · derivative · entry 2

CRANDALL ROBERT L · CIK 0001206595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,355,000

Underlying: Common Stock · 14,885 shares

Expires 2020-03-01

F3 · price: Represents the aggregate purchase price for the 3.75% senior convertible notes due 2020.

F1 · derivative.exercise_date: The 3.75% senior convertible notes due 2020 become convertible on December 1, 2019 or earlier upon certain events.

F2 · derivative.underlying_shares: The 3.75% senior convertible notes due 2020 are convertible into common stock at a conversion price equal to $23.85 per share of the issuer's common stock, subject to adjustment in certain events.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 22:37 UTC Purchase3.75% Senior Convertible Notes due 2020 · Derivative Not disclosed $811,880.00 Strike: $23.85 $1,000,000.00
Disclosure

SEC source: 0001209191-17-017828 · doc4.xml · derivative · entry 1

CRANDALL ROBERT L · CIK 0001206595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,000,000

Underlying: Common Stock · 41,929 shares

Expires 2020-03-01

F3 · price: Represents the aggregate purchase price for the 3.75% senior convertible notes due 2020.

F1 · derivative.exercise_date: The 3.75% senior convertible notes due 2020 become convertible on December 1, 2019 or earlier upon certain events.

F2 · derivative.underlying_shares: The 3.75% senior convertible notes due 2020 are convertible into common stock at a conversion price equal to $23.85 per share of the issuer's common stock, subject to adjustment in certain events.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 15:31 UTC
Jackson KarenSVP, Human Resources
Tax withholdingCommon Stock 379 $10.49 $3,975.71
Disclosure

SEC source: 0001209191-17-015615 · doc4.xml · nonDerivative · entry 1

Jackson Karen · CIK 0001634791 · SVP, Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,093

F1 · security: Includes restricted shares.

F2 · balance_after: Includes 2,947 shares acquired under Gogo Inc.'s employee stock purchase plan in transactions that were exempt under Rule 16b-3(c)

Read SEC document
February 22, 2017 Filed Feb 24, 2017 21:07 UTC
THORNE OAKLEIGHDirector · 10% owner
OtherCommon Stock 433,136 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-005226 · doc4.xml · nonDerivative · entry 1

Thorndale Farm LLC · CIK 0001455402 · 10% owner

THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 20,936

F1 · kind: The reported disposition was effected solely in connection with the long-term estate planning of Mr. Thorne and his family. This transfer was not effected in the open market.

F2 · ownership.direct: Reflects shares held by the Bertha P. Thorne Trust Under Will dated 12/23/1970 FBO Oakleigh B. Thorne. Mr. Thorne, as a co-trustee of the foregoing trust, may be deemed to have beneficial ownership of the shares held by the trust. Mr. Thorne disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Certain of the entities for which shares are reported on this report and certain other entities that hold the issuer's shares have entered into a service agreement with Thorndale Farm, L.L.C., of which Mr. Thorne is the Chief Executive Officer. As such, Thorndale Farm, L.L.C. and Mr. Thorne may be deemed to have beneficial ownership of the shares held by such entities. Thorndale Farm, L.L.C. and Mr. Thorne disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that either Thorndale Farm, L.L.C. or Mr. Thorne is a beneficial owner of such shares for purposes of Section 16 or for any other purpose.

Read SEC document
January 24, 2017 Filed Jan 26, 2017 21:15 UTC
THORNE OAKLEIGHDirector · 10% owner
OtherCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-17-001990 · doc4.xml · nonDerivative · entry 2

Thorndale Farm LLC · CIK 0001455402 · 10% owner

THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 1,037,306

F4 · kind: The reported disposition was effected solely in connection with the long-term estate planning of Mr. Thorne and his family. No shares were purchased or sold in connection with the disposition, nor was the transfer effected in the open market.

F2 · ownership.direct: Reflects shares held by the 2005 Restatement of the Oakleigh Thorne Trust dated June 23, 1997. Mr. Thorne, as trustee of the foregoing trust, may be deemed to have beneficial ownership of the shares held by the trust. Mr. Thorne disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.

F3 · ownership.direct: Certain of the entities for which shares are reported on this report and certain other entities that hold the issuer's shares have entered into a service agreement with Thorndale Farm, L.L.C., of which Mr. Thorne is the Chief Executive Officer. As such, Thorndale Farm, L.L.C. and Mr. Thorne may be deemed to have beneficial ownership of the shares held by such entities. Thorndale Farm, L.L.C. and Mr. Thorne disclaim beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that either Thorndale Farm, L.L.C. or Mr. Thorne is a beneficial owner of such shares for purposes of Section 16 or for any other purpose.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 14:27 UTC GrantOptions (Right to Buy) · Derivative 4,517 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000708 · doc4.xml · derivative · entry 2

MUNDHEIM ROBERT H · CIK 0001039520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 14:27 UTC GrantDeferred Share Units · Derivative 3,660 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000708 · doc4.xml · derivative · entry 1

MUNDHEIM ROBERT H · CIK 0001039520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,384

Underlying: Common Stock · 3,660 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 14:26 UTC GrantOptions (Right to Buy) · Derivative 6,130 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000706 · doc4.xml · derivative · entry 2

LEMAY RONALD T · CIK 0001104293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,130

Underlying: Common Stock · 6,130 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 14:26 UTC GrantDeferred Share Units · Derivative 2,575 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000706 · doc4.xml · derivative · entry 1

LEMAY RONALD T · CIK 0001104293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,083

Underlying: Common Stock · 2,575 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:28 UTC
THORNE OAKLEIGHDirector · 10% owner
GrantOptions (Right to Buy) · Derivative 4,517 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000710 · doc4.xml · derivative · entry 2

THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:28 UTC
THORNE OAKLEIGHDirector · 10% owner
GrantDeferred Share Units · Derivative 3,524 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000710 · doc4.xml · derivative · entry 1

THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,613

Underlying: Common Stock · 3,524 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:27 UTC GrantOptions (Right to Buy) · Derivative 4,517 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000709 · doc4.xml · derivative · entry 2

Payne Christopher D · CIK 0001612163 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:27 UTC GrantDeferred Share Units · Derivative 1,898 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000709 · doc4.xml · derivative · entry 1

Payne Christopher D · CIK 0001612163 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,076

Underlying: Common Stock · 1,898 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:30 UTC GrantOptions (Right to Buy) · Derivative 4,517 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000714 · doc4.xml · derivative · entry 2

WILLIAMS HARRIS N · CIK 0001579625 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:30 UTC GrantDeferred Share Units · Derivative 1,898 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000714 · doc4.xml · derivative · entry 1

WILLIAMS HARRIS N · CIK 0001579625 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,274

Underlying: Common Stock · 1,898 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:29 UTC GrantOptions (Right to Buy) · Derivative 4,517 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000712 · doc4.xml · derivative · entry 2

TOWNSEND CHARLES C · CIK 0001579494 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:29 UTC GrantDeferred Share Units · Derivative 3,253 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000712 · doc4.xml · derivative · entry 1

TOWNSEND CHARLES C · CIK 0001579494 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,145

Underlying: Common Stock · 3,253 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:26 UTC GrantOptions (Right to Buy) · Derivative 4,517 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000707 · doc4.xml · derivative · entry 2

MAYES MICHELE COLEMAN · CIK 0001224609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:26 UTC GrantDeferred Share Units · Derivative 3,253 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000707 · doc4.xml · derivative · entry 1

MAYES MICHELE COLEMAN · CIK 0001224609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,764

Underlying: Common Stock · 3,253 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:24 UTC GrantOptions (Right to Buy) · Derivative 4,517 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000703 · doc4.xml · derivative · entry 2

CRANDALL ROBERT L · CIK 0001206595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:24 UTC GrantDeferred Share Units · Derivative 3,253 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000703 · doc4.xml · derivative · entry 1

CRANDALL ROBERT L · CIK 0001206595 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,889

Underlying: Common Stock · 3,253 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:25 UTC
JONES HUGH WDirector
GrantOptions (Right to Buy) · Derivative 4,517 $0.00 Strike: $9.22 $0.00
Disclosure

SEC source: 0001209191-17-000705 · doc4.xml · derivative · entry 2

JONES HUGH W · CIK 0001182420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,517

Underlying: Common Stock · 4,517 shares

Expires 2026-12-30

Read SEC document
December 30, 2016 Filed Jan 4, 2017 19:25 UTC
JONES HUGH WDirector
GrantDeferred Share Units · Derivative 1,898 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-000705 · doc4.xml · derivative · entry 1

JONES HUGH W · CIK 0001182420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,793

Underlying: Common Stock · 1,898 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
November 11, 2016 Filed Nov 15, 2016 16:50 UTC
SMALL MICHAELDirector · President and CEO
PurchaseCommon Stock 50,000 $8.94 $446,850.00
Disclosure

SEC source: 0001209191-16-150026 · doc4.xml · nonDerivative · entry 1

SMALL MICHAEL · CIK 0001230004 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 294,832

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.65 to $9.18, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 09, 2016 Filed Nov 10, 2016 10:33 UTC PurchaseCommon Stock 5,000 $9.06 $45,283.00
Disclosure

SEC source: 0001209191-16-149237 · doc4.xml · nonDerivative · entry 2

MUNDHEIM ROBERT H · CIK 0001039520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,244

F3 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.05 to $9.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 08, 2016 Filed Nov 10, 2016 10:33 UTC PurchaseCommon Stock 5,000 $9.59 $47,926.00
Disclosure

SEC source: 0001209191-16-149237 · doc4.xml · nonDerivative · entry 3

MUNDHEIM ROBERT H · CIK 0001039520 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Wife

Disclosed balance after: 6,500

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.57 to $9.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Read SEC document
November 08, 2016 Filed Nov 10, 2016 10:33 UTC PurchaseCommon Stock 5,000 $9.63 $48,126.00
Disclosure

SEC source: 0001209191-16-149237 · doc4.xml · nonDerivative · entry 1

MUNDHEIM ROBERT H · CIK 0001039520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,244

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.55 to $9.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · balance_after: Reflects receipt of shares in connection with a pro rata distribution from Blumenstein/Thorne Aircell Partners, LP, of which the reporting person was a limited partner, exempt under Rule 16a-9.

Read SEC document
November 07, 2016 Filed Nov 9, 2016 16:10 UTC PurchaseCommon Stock 300,000 $9.69 $2,908,350.00
Disclosure

SEC source: 0001209191-16-148982 · doc4.xml · nonDerivative · entry 1

TOWNSEND CHARLES C · CIK 0001579494 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 654,267

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.60 to $9.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2 · ownership.direct: Reflects shares held by the Charles C. Townsend III Trust. Mr Townsend, as a co-trustee of the foregoing trust, may be deemed to have beneficial ownership of the shares held by the trust. Mr. Townsend disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that he is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.

Read SEC document
September 30, 2016 Filed Oct 4, 2016 11:24 UTC GrantOptions (Right to Buy) · Derivative 3,892 $0.00 Strike: $11.04 $0.00
Disclosure

SEC source: 0001209191-16-143820 · doc4.xml · derivative · entry 2

MUNDHEIM ROBERT H · CIK 0001039520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,892

Underlying: Common Stock · 3,892 shares

Expires 2026-09-30

Read SEC document
September 30, 2016 Filed Oct 4, 2016 11:24 UTC GrantDeferred Share Units · Derivative 3,057 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-143820 · doc4.xml · derivative · entry 1

MUNDHEIM ROBERT H · CIK 0001039520 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,724

Underlying: Common Stock · 3,057 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
September 30, 2016 Filed Oct 4, 2016 11:22 UTC GrantOptions (Right to Buy) · Derivative 5,282 $0.00 Strike: $11.04 $0.00
Disclosure

SEC source: 0001209191-16-143818 · doc4.xml · derivative · entry 2

LEMAY RONALD T · CIK 0001104293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,282

Underlying: Common Stock · 5,282 shares

Expires 2026-09-30

Read SEC document
September 30, 2016 Filed Oct 4, 2016 11:22 UTC GrantDeferred Share Units · Derivative 2,151 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-143818 · doc4.xml · derivative · entry 1

LEMAY RONALD T · CIK 0001104293 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,508

Underlying: Common Stock · 2,151 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
September 30, 2016 Filed Oct 4, 2016 15:25 UTC
THORNE OAKLEIGHDirector · 10% owner
GrantOptions (Right to Buy) · Derivative 3,892 $0.00 Strike: $11.04 $0.00
Disclosure

SEC source: 0001209191-16-143822 · doc4.xml · derivative · entry 2

THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,892

Underlying: Common Stock · 3,892 shares

Expires 2026-09-30

Read SEC document
September 30, 2016 Filed Oct 4, 2016 15:25 UTC
THORNE OAKLEIGHDirector · 10% owner
GrantDeferred Share Units · Derivative 2,943 $0.00 $0.00
Disclosure

SEC source: 0001209191-16-143822 · doc4.xml · derivative · entry 1

THORNE OAKLEIGH · CIK 0001135089 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,089

Underlying: Common Stock · 2,943 shares

Expires not disclosed

F1 · derivative.exercise_price: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.exercise_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

F1 · derivative.expiration_date: Deferred stock units that are settled in shares of common stock 90 days after the director ceases service as a director.

Read SEC document
September 30, 2016 Filed Oct 4, 2016 15:24 UTC GrantOptions (Right to Buy) · Derivative 3,892 $0.00 Strike: $11.04 $0.00
Disclosure

SEC source: 0001209191-16-143821 · doc4.xml · derivative · entry 2

Payne Christopher D · CIK 0001612163 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,892

Underlying: Common Stock · 3,892 shares

Expires 2026-09-30

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.